CSI Market
Sign In | Register

The Oncology Institute Inc (TOI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TOI Annual Balance Sheets →
This balance sheet overview for The Oncology Institute Inc spans from Mar 31 2025 to Mar 31 2026, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & Short-term Investments0.00
Accounts receivable58.13
Other Receivables, Net, Current1.32
Inventories24.29
Other Current Assets30.28
Prepaid Expense And Other Assets Current2.84
Total Current Assets116.86
Equipment/Property/Plant Net10.70
Goodwill net7.23
Intangible Assets10.30
Other Assets, Noncurrent23.14
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents30.28
Operating Lease Right Of Use Asset22.52
Total Assets168.23
Liabilities
Accounts Payable, Current AC47.65
Accrued Liabilities, Current AC24.30
Other Liabilities, Current7.40
Total Current Liabilities79.35
Long-term debt78.61
Total Long-term Debt78.61
Derivative Liability, Noncurrent DE7.60
Other liabilities, Noncurrent18.96
Operating Lease Liability Current7.40
Derivative Warrant Liabilities Noncurrent0.10
Total Liabilities184.52
Stockholders' Equity
Treasury Stock Common Value-1.02
Common Stock Value0.01
Additional Paid In Capital Common Stock258.64
Retained Earnings / Accumulated Deficit-273.91
Other Equity0.00
Common Stockholder's Equity-16.29
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-16.29
Liabilities & Stockholder's Equity168.23
4 historic quarters locked

Sign in to unlock the full The Oncology Institute Inc balance sheet history.

Sign In Create Free Account

About Starling Oncology Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 6, 2026
  • Source: toi-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001799191-26-000017

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.